Breakthrough Test Enhances Peripheral Neuropathy Care and Research

From Answers from the Lab by Mayo Clinic Laboratories

March 5, 2026 · 17 min · Episode 379

About this episode

This episode discusses diagnostic innovations in patient care, focusing on a novel test for peripheral neuropathy.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , president and CEO of Mayo Clinic Laboratories, to explore recent examples of diagnostic innovations that are improving patient care. Dr. Pritt also welcomes Matthew Schultz, Ph.D. , a clinical biochemical geneticist at Mayo Clinic, to discuss how a novel test is delivering answers for patients with a recently identified peripheral neuropathy. Transplant testing innovations (00:57): Discover how advances in clinical diagnostics are improving transplant outcomes at Mayo Clinic. Advances reshaping rheumatoid arthritis diagnostics (06:06) : Learn how early-stage research and emerging tools are reshaping care for patients with rheumatoid arthritis. New test for peripheral neuropathy (08:18) : A novel test created to support care for patients with a recently identified condition now supporting research to advance care. Note: Information in this post was accurate at the time of its posting. Resources Rewriting the future of rheumatoid arthritis: How early detection is transforming prevention Cultivating a…

People in this episode

Host: Bobbi Pritt, M.D.

Guests: William Morice II, M.D., Ph.D., Matthew Schultz, Ph.D.

Topics covered

diagnostic innovations
patient care
peripheral neuropathy
transplant testing
rheumatoid arthritis
clinical diagnostics

Keywords

peripheral neuropathy
diagnostic innovations
Mayo Clinic
rheumatoid arthritis
transplant testing
clinical diagnostics

Mentioned in this episode

Organizations: Mayo Clinic, Mayo Clinic Laboratories